Recent Sentinel Activity

This recent activity feed provides a list of the last 90 days of Sentinel activity across assessments, publications & presentations, projects, events, etc.

RSS Feed

URL	Title	Category	Date	Recent Activity
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/34th-international-conference-pharmacoepidemiology-and	34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management	Sentinel Initiative Events	08/21/2018	34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management Sentinel Initiative Events 08/21/2018
https://www.sentinelinitiative.org/methods-data-tools/methods/near-real-time-monitoring-critical-drugs-care-patients-covid-19	Near Real-Time Monitoring of Critical Drugs for the Care of Patients with COVID-19	Methods, Data, & Tools	04/20/2020	Near Real-Time Monitoring of Critical Drugs for the Care of Patients with COVID-19 Methods, Data, & Tools 04/20/2020
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/36th-international-conference-pharmacoepidemiology-and	36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management	Publications and Presentations	09/16/2020	36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management Publications and Presentations 09/16/2020
https://www.sentinelinitiative.org/news-events/publications-presentations/covid-19-ready-public-health-surveillance-system-food-and	A COVID‐19‐Ready Public Health Surveillance System: The Food and Drug Administration's Sentinel System	Publications and Presentations	04/18/2021	A COVID‐19‐Ready Public Health Surveillance System: The Food and Drug Administration's Sentinel System Publications and Presentations 04/18/2021
https://www.sentinelinitiative.org/news-events/publications-presentations/strategies-use-real-world-data-conduct-covid-19-related	Strategies for the Use of Real-World Data to Conduct COVID-19-Related Pharmacoepidemiology	Publications and Presentations	08/25/2021	Strategies for the Use of Real-World Data to Conduct COVID-19-Related Pharmacoepidemiology Publications and Presentations 08/25/2021
https://www.sentinelinitiative.org/methods-data-tools/methods/making-medicaid-data-more-accessible-through-common-data-models-and-fhir	Making Medicaid Data More Accessible Through Common Data Models and FHIR APIs	Methods, Data, & Tools	09/24/2021	Making Medicaid Data More Accessible Through Common Data Models and FHIR APIs Methods, Data, & Tools 09/24/2021
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/n-nitrosodimethylamine-ndma-contaminated-and-non-ndma	N‐nitrosodimethylamine (NDMA)‐Contaminated and Non‐NDMA‐Contaminated Valsartan Use: A Descriptive Analysis	Analyses	02/18/2022	N‐nitrosodimethylamine (NDMA)‐Contaminated and Non‐NDMA‐Contaminated Valsartan Use: A Descriptive Analysis Analyses 02/18/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/incidence-and-prevalence-n-nitrosodimethylamine-ndma-and-n	Incidence and Prevalence of N-Nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA) Contaminated Valsartan Use: A Descriptive Analysis	Analyses	03/01/2022	Incidence and Prevalence of N-Nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA) Contaminated Valsartan Use: A Descriptive Analysis Analyses 03/01/2022
https://www.sentinelinitiative.org/methods-data-tools/methods/augmenting-date-death-cause-death-ascertainment-sentinel	Augmenting Date of Death & Cause of Death Ascertainment in Sentinel	Methods, Data, & Tools	03/16/2022	Augmenting Date of Death & Cause of Death Ascertainment in Sentinel Methods, Data, & Tools 03/16/2022
https://www.sentinelinitiative.org/news-events/publications-presentations/impact-nitrosamine-contamination-recalls-angiotensin	Impact of Nitrosamine Contamination Recalls on Angiotensin-Receptor-Blocker (ARB) Utilization in the U.S., U.K., Canada, and Denmark	Publications and Presentations	08/26/2022	Impact of Nitrosamine Contamination Recalls on Angiotensin-Receptor-Blocker (ARB) Utilization in the U.S., U.K., Canada, and Denmark Publications and Presentations 08/26/2022
https://www.sentinelinitiative.org/news-events/publications-presentations/systemic-corticosteroids-covid-19-us-outpatient-settings	Systemic Corticosteroids for COVID-19 in U.S. Outpatient Settings	Publications and Presentations	08/28/2022	Systemic Corticosteroids for COVID-19 in U.S. Outpatient Settings Publications and Presentations 08/28/2022
https://www.sentinelinitiative.org/news-events/publications-presentations/valsartan-losartan-and-irbesartan-use-usa-uk-canada-and	Valsartan, Losartan and Irbesartan Use in the USA, UK, Canada and Denmark After the Nitrosamine Recalls: A Descriptive Cohort Study	Publications and Presentations	04/17/2023	Valsartan, Losartan and Irbesartan Use in the USA, UK, Canada and Denmark After the Nitrosamine Recalls: A Descriptive Cohort Study Publications and Presentations 04/17/2023
https://www.sentinelinitiative.org/methods-data-tools/methods/subset-calibration-methods	Subset Calibration Methods	Methods, Data, & Tools	05/08/2023	Subset Calibration Methods Methods, Data, & Tools 05/08/2023
https://www.sentinelinitiative.org/studies/drugs/zarxio-filgrastim-sndz	Zarxio (Filgrastim-sndz) & Signal Identification	Studies	06/01/2023	Zarxio (Filgrastim-sndz) & Signal Identification Studies 06/01/2023
https://www.sentinelinitiative.org/news-events/publications-presentations/treatment-and-care-received-children-hospitalized-covid-19	Treatment and Care Received by Children Hospitalized with COVID-19 in a Large Hospital Network in the United States, February 2020 to September 2021	Publications and Presentations	07/11/2023	Treatment and Care Received by Children Hospitalized with COVID-19 in a Large Hospital Network in the United States, February 2020 to September 2021 Publications and Presentations 07/11/2023
https://www.sentinelinitiative.org/methods-data-tools/methods/utilization-single-and-multiple-inhaler-triple-therapy-among-patients	Utilization of Single and Multiple Inhaler Triple Therapy Among Patients with COPD in the Sentinel Distributed Database	Methods, Data, & Tools	07/31/2023	Utilization of Single and Multiple Inhaler Triple Therapy Among Patients with COPD in the Sentinel Distributed Database Methods, Data, & Tools 07/31/2023
https://www.sentinelinitiative.org/news-events/publications-presentations/high-dose-dexamethasone-covid-19-not-common-large-us	High Dose Dexamethasone for COVID-19 Not Common in a Large US Hospital Network	Publications and Presentations	08/25/2023	High Dose Dexamethasone for COVID-19 Not Common in a Large US Hospital Network Publications and Presentations 08/25/2023
https://www.sentinelinitiative.org/news-events/publications-presentations/investigating-potential-differences-safety-profiles	Investigating Potential Differences in the Safety Profiles of Biosimilars Relative to Originator Products Using a Tree-Based Scan Statistic	Publications and Presentations	08/27/2023	Investigating Potential Differences in the Safety Profiles of Biosimilars Relative to Originator Products Using a Tree-Based Scan Statistic Publications and Presentations 08/27/2023
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-gimoti-metoclopramide-nasal-spray-0	Characterization of Gimoti (Metoclopramide Nasal Spray) Dispensing Patterns: A Second Descriptive Analysis	Analyses	03/08/2024	Characterization of Gimoti (Metoclopramide Nasal Spray) Dispensing Patterns: A Second Descriptive Analysis Analyses 03/08/2024
https://www.sentinelinitiative.org/news-events/publications-presentations/validity-inpatient-electronic-health-record-based-measures	Validity of Inpatient Electronic Health Record-Based Measures of Oxygen-Related Therapy in the United States: Lessons Applicable for Studying COVID-19 Endpoints	Publications and Presentations	04/02/2024	Validity of Inpatient Electronic Health Record-Based Measures of Oxygen-Related Therapy in the United States: Lessons Applicable for Studying COVID-19 Endpoints Publications and Presentations 04/02/2024
https://www.sentinelinitiative.org/studies/drugs/brexafemme-ibrexafungerp	Brexafemme (Ibrexafungerp) & Use in Pregnancy	Studies	07/17/2024	Brexafemme (Ibrexafungerp) & Use in Pregnancy Studies 07/17/2024
https://www.sentinelinitiative.org/news-events/publications-presentations/high-dimensional-multiple-imputation-hdmi-strategies	High-Dimensional Multiple Imputation (hdMI) Strategies for Partially Observed Confounders with Structured and Natural Language Processing-Derived Auxiliary Covariates	Publications and Presentations	08/27/2024	High-Dimensional Multiple Imputation (hdMI) Strategies for Partially Observed Confounders with Structured and Natural Language Processing-Derived Auxiliary Covariates Publications and Presentations 08/27/2024
https://www.sentinelinitiative.org/news-events/publications-presentations/characterizing-inpatient-electronic-health-records-ehr-large	Characterizing Inpatient Electronic Health Records (EHR) from a Large Hospital Network for Use in Neonatal Pharmacoepidemiology Studies in the United States	Publications and Presentations	08/28/2024	Characterizing Inpatient Electronic Health Records (EHR) from a Large Hospital Network for Use in Neonatal Pharmacoepidemiology Studies in the United States Publications and Presentations 08/28/2024
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-guselkumab-use-signal	Outcome Monitoring Following Guselkumab Use: A Signal Identification Analysis	Analyses	09/17/2024	Outcome Monitoring Following Guselkumab Use: A Signal Identification Analysis Analyses 09/17/2024
https://www.sentinelinitiative.org/news-events/publications-presentations/exposure-valsartan-products-containing-nitrosamine	Exposure to Valsartan Products Containing Nitrosamine Impurities in the United States, Canada, and Denmark	Publications and Presentations	09/18/2024	Exposure to Valsartan Products Containing Nitrosamine Impurities in the United States, Canada, and Denmark Publications and Presentations 09/18/2024
https://www.sentinelinitiative.org/news-events/publications-presentations/applications-real-world-data-rwd-fda-s-sentinel-system	Applications of Real-World Data (RWD) in FDA’s Sentinel System	Publications and Presentations	10/24/2024	Applications of Real-World Data (RWD) in FDA’s Sentinel System Publications and Presentations 10/24/2024
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-guselkumab-use-signal-0	Outcome Monitoring Following Guselkumab Use: A Signal Identification and Self-Controlled Risk Interval Analysis	Analyses	11/01/2024	Outcome Monitoring Following Guselkumab Use: A Signal Identification and Self-Controlled Risk Interval Analysis Analyses 11/01/2024
https://www.sentinelinitiative.org/news-events/publications-presentations/high-dimensional-multiple-imputation-hdmi-partially-observed	High-Dimensional Multiple Imputation (HDMI) for Partially Observed Confounders Including Natural Language Processing-Derived Auxiliary Covariates	Publications and Presentations	01/22/2025	High-Dimensional Multiple Imputation (HDMI) for Partially Observed Confounders Including Natural Language Processing-Derived Auxiliary Covariates Publications and Presentations 01/22/2025
https://www.sentinelinitiative.org/news-events/publications-presentations/interplay-adverse-events-spontaneous-reporting-and	Interplay of Adverse Events, Spontaneous Reporting, and Longitudinal Electronic Health Records for Signal Management	Publications and Presentations	01/27/2025	Interplay of Adverse Events, Spontaneous Reporting, and Longitudinal Electronic Health Records for Signal Management Publications and Presentations 01/27/2025
https://www.sentinelinitiative.org/news-events/publications-presentations/practical-overview-real-life-challenges-leveraging-ehr-data	A Practical Overview of Real-Life Challenges Leveraging EHR Data for the FDA Sentinel System	Publications and Presentations	02/14/2025	A Practical Overview of Real-Life Challenges Leveraging EHR Data for the FDA Sentinel System Publications and Presentations 02/14/2025
https://www.sentinelinitiative.org/news-events/publications-presentations/cautionary-note-plasmode-simulation-studies-setting-causal	A Cautionary Note for Plasmode Simulation Studies in the Setting of Causal Inference	Publications and Presentations	03/25/2025	A Cautionary Note for Plasmode Simulation Studies in the Setting of Causal Inference Publications and Presentations 03/25/2025
https://www.sentinelinitiative.org/methods-data-tools/routine-querying-tools/sentinel-routine-querying-system	Sentinel Routine Querying System	Methods, Data, & Tools	04/01/2025	Sentinel Routine Querying System Methods, Data, & Tools 04/01/2025
https://www.sentinelinitiative.org/methods-data-tools/routine-querying-tools/sentinel-routine-querying-system-reporting-tool	Sentinel Routine Querying System Reporting Tool	Methods, Data, & Tools	04/01/2025	Sentinel Routine Querying System Reporting Tool Methods, Data, & Tools 04/01/2025
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-patterns-inhaler-triple-therapy-patients-chronic	Utilization Patterns of Inhaler Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease (COPD): A Descriptive Analysis	Analyses	05/01/2025	Utilization Patterns of Inhaler Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease (COPD): A Descriptive Analysis Analyses 05/01/2025
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/prescriptions-and-dispensings-central-nervous-system-cns	Prescriptions and Dispensings of Central Nervous System (CNS) Stimulants: A Descriptive Analysis	Analyses	05/06/2025	Prescriptions and Dispensings of Central Nervous System (CNS) Stimulants: A Descriptive Analysis Analyses 05/06/2025
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2022-first	Duration of Follow Up for New Molecular Entities Approved in 2022: First Descriptive Analysis	Analyses	05/06/2025	Duration of Follow Up for New Molecular Entities Approved in 2022: First Descriptive Analysis Analyses 05/06/2025
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/livdelzi-seladelpar	Assessment of ARIA Sufficiency: Livdelzi (seladelpar)	Sufficiency Assessments	05/09/2025	Assessment of ARIA Sufficiency: Livdelzi (seladelpar) Sufficiency Assessments 05/09/2025
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/valsartan-and-non-valsartan-angiotensin-receptor-blocker-1	Valsartan and Non-Valsartan Angiotensin Receptor Blocker Utilization in Canada Following Recalls Due to Nitrosamine Impurities: A Descriptive Analysis	Analyses	05/13/2025	Valsartan and Non-Valsartan Angiotensin Receptor Blocker Utilization in Canada Following Recalls Due to Nitrosamine Impurities: A Descriptive Analysis Analyses 05/13/2025
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/valsartan-and-non-valsartan-angiotensin-receptor-blocker	Valsartan and Non-Valsartan Angiotensin Receptor Blocker Utilization in Denmark Following Recalls Due to Nitrosamine Impurities: A Descriptive Analysis	Analyses	05/13/2025	Valsartan and Non-Valsartan Angiotensin Receptor Blocker Utilization in Denmark Following Recalls Due to Nitrosamine Impurities: A Descriptive Analysis Analyses 05/13/2025
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/valsartan-and-non-valsartan-angiotensin-receptor-blocker-0	Valsartan and Non-Valsartan Angiotensin Receptor Blocker Utilization in the United Kingdom Following Recalls Due to Nitrosamine Impurities: A Descriptive Analysis	Analyses	05/13/2025	Valsartan and Non-Valsartan Angiotensin Receptor Blocker Utilization in the United Kingdom Following Recalls Due to Nitrosamine Impurities: A Descriptive Analysis Analyses 05/13/2025